世界卫生组织与韩国签署谅解备忘录，计划在韩国建立全球生物制造培训中心1。该中心将为所有低收入和中等收入国家培养疫苗、胰岛素、单克隆抗体等生物制品的生产人才1。韩国计划在2025年启动全球生物教育园区，以扩大培训容量1。
WHO助理总干事Yukiko Nakatani称此举为"将伙伴关系提升到新水平"1。WHO同步加强监管体系建设，确保本地生产产品的质量安全1。韩国卫生福祉部全球疫苗中心办公室主任Hwang Seunghyun表示，此举将加强低收入和中等收入国家的生物制造能力1。WHO已在2023年4月在南非建立了mRNA技术转移中心1。
The World Health Organization and the Republic of Korea have signed a memorandum of understanding to establish a global biomanufacturing training center aimed at strengthening production capabilities in low-income and middle-income countries 1. The center will prepare personnel to manufacture vaccines, insulin, monoclonal antibodies, and other biopharmaceutical products 1.
South Korea will launch a Global Bioeducation Park in 2025 to expand the training capacity of the initiative 1. In parallel, the WHO is reinforcing its regulatory framework to ensure the quality and safety of locally manufactured products 1. WHO Assistant Director-General Yukiko Nakatani characterized the partnership as "elevating collaboration to a new level" 1, while Hwang Seunghyun, Director of the Global Vaccine Center Office at South Korea's Ministry of Health and Welfare, emphasized that the agreement will enhance biomanufacturing capabilities in low-income and middle-income countries 1.
This partnership builds on earlier WHO efforts, including the establishment of an mRNA technology transfer center in South Africa in April 2023 1.
评论
还没有评论，欢迎留下第一条。